Zhang et al. [138] investigated the effect of miR-1294 on platinum-resistant ovarian cancer and documented that miR-1294 dysregulation manipulated ovarian cancer cisplatin resistance through regulating IGF1R. This evidence concerns the gene IGF1R and ovarian carcinoma.